Treatment Challenges in Pediatric Stroke Patients

Table 5

The risk factors and prothrombotic risk factors of patients who received prophylaxis.

Risk Factors	Cholesterol	Triglyceride	High-CRP	Fibrinogen	Homocysteine	Lipoprotein A	Factor VIII	Factor IX	Protein S	Protein C	Antithrombin III	APCR	Factor V Leiden	MTHFR	Prothrombin 20210	Total
Protein S deficiency	—	1	—	—	—	—	1	—	3	—	—	—	1	—	—	3
Congenital heart disease	—	—	—	—	3	1	3	2	—	3	1	—	—	1	—	5
Moyamoya disease	—	—	—	—	1	—	—	—	—	—	—	—	—	1	—	1
Undergone varicella	1	1	—	—	—	—	—	—	—	—	—	—	—	—	—	1
Cyclosporin toxicity	—	—	—	1	—	—	—	—	—	—	—	—	—	—	—	1
Rheumatic heart disease	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1
Thalassemia major- BMT°	—	—	—	—	1	—	—	—	—	—	—	—	—	1	—	1
other∗	—	—	—	1	2	1	2	1	—	—	—	1	2	3	—	4
Total	—															17

∗One of the patients had heterozygous factor V Leiden mutation, one had MTHFR homozygote mutation, one had antiphospholipid antibody syndrome, and the other patient had megaloblastic anemia with MTHFR heterozygote mutation. °bone marrow transplantation.